End in sight for U.S. insider trading case over healthcare leaks

By Jonathan Stempel NEW YORK (Reuters) -A long-running federal insider trading case based on leaks about planned changes to Medicare reimbursement rates will likely end with no convictions, after the remaining defendants agreed to enter deferred prosecution agreements. Theodore Huber and Robert Olan, who were partners at the hedge fund Deerfield Management, and David Blaszczak,…

Read More

Zimmer Biomet’s downbeat 2024 view hits shares after forecast raise

By Mariam Sunny (Reuters) -Zimmer Biomet Holdings on Tuesday raised its full-year profit forecast after beating second-quarter estimates on demand for its medical devices but shares fell more than 5% as investors focused on the company’s comments for 2024. Expectations were high heading into the results following strong reports from Abbott Laboratories and Johnson &…

Read More

Caterpillar’s 2023 margin forecast, upbeat results send shares to record high

By Shivansh Tiwary (Reuters) -Caterpillar Inc said on Tuesday that strong demand for heavy machinery from construction and mining industries was expected to drive full-year operating margin near the top end of its prior forecast, sending its shares to a record high. The company, seen as a proxy for global economic activity, also reported better-than-expected…

Read More

Marathon Petroleum profit beats forecasts but slumps 63% on lower refining margins

By Laura Sanicola and Arshreet Singh (Reuters) – U.S. refiner Marathon Petroleum Corp reported a 63% drop in second-quarter profit on Tuesday, as improved fuel supplies and slowing economic activity compressed its margins. Despite resilient fuel demand in the U.S., an increase in global refining capacity over the last year and slowing economic activity has…

Read More